Comparison of Prothrombin Time and Aspartate Aminotransferase in Predicting Hepatotoxicity After Acetaminophen Overdose

详细信息    查看全文

• 作者：Michael Levine ; Ayrn D. O'Connor ; Angela Padilla-Jones…
• 关键词：Acetaminophen ; Coagulopathy ; Hepatic failure ; Overdose
• 刊名：Journal of Medical Toxicology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：12
• 期：1
• 页码：100-106
• 全文大小：344 KB
• 参考文献：1.Rhyee SH, Farrugia L, Wiegand T, et al. The toxicology investigators consortium case registry—the 2012 experience. J Med Toxicol. 2013;9:380–404.CrossRef
  2.Mowry JB, Spyker DA, Cantilena Jr LR, et al. 2013 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st annual report. Clin Toxicol. 2014;52:1032–283.CrossRef
  3.Hinson JA, Roberts DW, James LP. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol. 2010;196:369–405.CrossRef PubMed
  4.Chun LJ, Tong MJ, Busuttil RW. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol. 2009;43:342–9.CrossRef PubMed
  5.Green TJ, Silvotti ML, Langmann C, et al. When do the aminotransferases rise after acute acetaminophen overdose. Clin Toxicol. 2010;48:787–92.CrossRef
  6.Hendrickson RG. Acetaminophen. In: Nelson LS, Hoffman RS, Lewin NA, et al., editors. Goldfrank’s toxicologic emergencies. 9th ed. New York: McGraw Hill Medical; 2011. p. 483–99.
  7.Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839–43.CrossRef PubMed
  8.Harrison PM, O’Grady JG, Keays RT, et al. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ. 1990;301:964–6.CrossRef PubMed PubMedCentral
  9.O’Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.PubMed
  10.Van der Steeg J, Akhtar J, Burkhart KK, et al. Initial prothrombin time as a predictor of acetaminophen-induced hepatotoxicity. J Toxicol Clin Toxicol. 1995;33:508–9. abstract.
  11.Van der Steeg J, DiSanto SK, Abendroth TW, et al. The effect of acetaminophen on the prothrombin time assay. J Toxicol Clin Toxicol. 1995;33:512. abstract.
  12.Whyte IM, Buckley NA, Reith DM, et al. Acetaminophen causes an increased international normalized ratio by reducing functional factor VII. Ther Drug Monit. 2000;22:742–8.CrossRef PubMed
  13.Buckley NA, Dawson AH. Drug interactions with warfarin. Med J Aust. 1993;158:574–5.
  14.Mahe I, Bertrand N, Drouet L, et al. Paracetamol: a hemorrhagic risk factor in patients on warfarin. Br J Clin Pharmacol. 2005;59:371–4.CrossRef PubMed PubMedCentral
  15.Mahe I, Bertrand N, Drouet L, et al. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study. Haematologica. 2006;91:1621–7.PubMed
  16.Parra D, Beckey NP, Stevens GR. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy. Pharmacotherapy. 2007;27:675–83.CrossRef PubMed
  17.Zhang Q, Bal-dit-Sollier C, Drouet L, et al. Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial. Eur J Clin Pharmacol. 2011;67:309–14.CrossRef PubMed
  18.Thijssen HH, Soute BA, Vervoot LM, et al. Paracetamol (acertaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle. Thromb Haemost. 2004;92:797–802.PubMed
  19.Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut. 1975;16:617–20.CrossRef PubMed PubMedCentral
  20.Pizon AF, Jang DH, Wang HE. The in vitro effect of N-acetylcysteine on prothrombin time in plasma samples from healthy subjects. Acad Emerg Med. 2011;18:351–4.CrossRef PubMed
  21.Jang DH, Weaver MD, Pizon AF. In vitro study of N-acetylcysteine on coagulation factors in plasma samples from healthy subjects. J Med Toxicol. 2013;9:49–53.CrossRef PubMed PubMedCentral
  22.Jepsen S, Hansen AB. The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects. Scand J Clin Lab Invest. 1994;54:543–7.CrossRef PubMed
  23.Schmidt LE, Knudsen TT, Dalhoff K, et al. Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury. Lancet. 2002;360:1151–2.CrossRef PubMed
  24.Lucena MI, Lopez-Torres E, Verge C, et al. The administration of N-acetylcysteine causes a decrease in Prothrombin time in patients with paracetamol overdose but without evidence of liver impairment. Eur J Gastroenterol Hepatol. 2005;17:59–63.CrossRef PubMed
  25.Chuang J, Sadler MA, Witt DM. Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5 ml (pediatric) tubes. Chest. 2004;126:1262–6.CrossRef PubMed
  26.Humphreys RE, McPhendran P. False elevation of partial thromboplastin time and prothrombin time. JAMA. 1970;214(9):1702–4.CrossRef PubMed
  27.Gilbert EH, Lowenstein SR, Koziol-McLain J, et al. Chart reviews in emergency medicine research: what are the methods? Ann Emerg Med. 1996;27:305–8.CrossRef PubMed
  28.Prescott LF, Park J, Ballantyne A, et al. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet. 1977;2:432–4.CrossRef PubMed
  
• 作者单位：Michael Levine (1) (2)
  Ayrn D. O’Connor (2) (3)
  Angela Padilla-Jones (4)
  Richard D. Gerkin (3) (4) (5)
  
  1. Department of Emergency Medicine, Division of Medical Toxicology, University of Southern California, Los Angeles, CA, USA
  2. Department of Medical Toxicology, Banner Good Samaritan Medical Center, Phoenix, AZ, USA
  3. Center for Toxicology and Pharmacology, Education, and Research, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA
  4. Banner Research Institute, Phoenix, AZ, USA
  5. Department of Internal Medicine, Banner Good Samaritan Medical Center, Phoenix, AZ, USA
  
• 刊物主题：Pharmacology/Toxicology; Biomedicine general;
• 出版者：Springer US
• ISSN：1937-6995

文摘

Despite decades of experience with acetaminophen (APAP) overdoses, it remains unclear whether elevated hepatic transaminases or coagulopathy develop first. Furthermore, comparison of the predictive value of these two variables in determining hepatic toxicity following APAP overdoses has been poorly elucidated. The primary objective of this study is to determine the test characteristics of the aspartate aminotransferase (AST) and the prothrombin time (PT) in patients with APAP toxicity. A retrospective chart review of APAP overdoses treated with IV N-acetylcysteine at a tertiary care referral center was performed. Of the 304 subjects included in the study, 246 with an initial AST less than 1000 were analyzed to determine predictors of hepatic injury, defined as an AST exceeding 1000 IU/L. The initial AST >50 was 79.5 % sensitive and 82.6 % specific for predicting hepatic injury. The corresponding negative and positive predictive values were 95.5 and 46.3 %, respectively. In contrast, an initial abnormal PT had a sensitivity of 82.1 % and a specificity of 63.6 %. The negative and positive predictive values for initial PT were 94.9 and 30.2 %, respectively. Although the two tests performed similarly for predicting a composite endpoint of death or liver transplant, neither was a useful predictor. Initial AST performed better than the initial PT for predicting hepatic injury in this series of patients with APAP overdose.